• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,677.54 -986.46
( -1.27%)
Global Indices
Nasdaq
49,330.80 -180.24
(-0.36%)
Dow Jones
7,129.46 -29.44
(-0.41%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,468.22 -8.24
(-0.08%)
Forex
USD-INR
93.75 0.31
(0.34%)
EUR-INR
109.98 0.10
(0.09%)
GBP-INR
126.66 0.42
(0.33%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
92.35
403052.28
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.95
 

IndiaMART shares rally on Nalanda Capital bulk deal buy
Jan 16,2026
According to exchange data, Nalanda India Equity Fund, managed by Nalanda Capital, acquired 11.18 lakh shares, representing a 1.86% stake, at Rs 2,110 per share.

In the same transaction, Small Cap World Fund, managed by Capital Group, sold 6.26 lakh shares, or a 1.04% stake, for Rs 132.17 crore at the same price. The fund held a 1.83% stake in the company at the end of the September quarter.

IndiaMART's promoters currently hold a 49.17% stake. The company's shareholding pattern for the December quarter is yet to be released.

IndiaMART is India's largest online B2B marketplace for business products and services.

On a consolidated basis, net profit of IndiaMART InterMESH declined 38.79% to Rs 82.70 crore while net sales rose 12.45% to Rs 391.00 crore in Q2 September 2025 over Q2 September 2024.